This delayed SARS‐CoV‐2‐specific antibody response may be due to the reduction of CD4+ T lymphocyte counts during HIV infection, as reported by numerous studies in the USA (20%), China (15.63%), and Italy (12.5%). This evidence concerns the gene CD4 and HIV infectious disease.